Kuriakose Emil
CIK 0001892413
Chief Medical Officer
Filings
14
Latest May 5, 2026
Issuers covered
2
Showing
14 of 14
Page 1
Track record
7 of 7 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 7 | 43% | -8.2% | -0.3% | +22.9% | -51.4% |
| 90 days | 6 | 17% | -95.8% | -38.6% | +56.1% | -419.7% |
| 180 days | 4 | 25% | -431.8% | -390.7% | +32.1% | -977.9% |
| 365 days | 2 | 0% | -1284.8% | -1284.8% | -607.4% | -1962.1% |
Issuers
Companies where Kuriakose Emil has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TERN | Terns Pharmaceuticals, Inc. | 10 | May 5, 2026 |
| CALA | Calithera Biosciences, Inc. | 4 | Jan 25, 2023 |
All filings
14 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|